NeoGenomics
NEO
#5064
Rank
$1.67 B
Marketcap
$12.93
Share price
3.52%
Change (1 day)
2.38%
Change (1 year)

Market capitalization of NeoGenomics (NEO)

Market cap: $1.67 Billion USD

As of January 2026 NeoGenomics has a market cap of $1.67 Billion USD. This makes NeoGenomics the world's 5064th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NeoGenomics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026$1.67 B5.29%
2025$1.58 B-26.45%
2024$2.16 B4.75%
2023$2.06 B76.72%
2022$1.16 B-72.22%
2021$4.20 B-29.72%
2020$5.97 B95.04%
2019$3.06 B157.29%
2018$1.19 B67.2%
2017$0.71 B5.88%
2016$0.67 B12.76%
2015$0.59 B137.53%
2014$0.25 B41.28%
2013$0.17 B58.34%
2012$0.11 B85.52%
2011$60.53 M24.42%
2010$48.65 M-12.78%
2009$55.77 M188.34%
2008$19.34 M-42.94%
2007$33.9 M-16.48%
2006$40.59 M835.52%
2005$4.33 M-19.42%
2004$5.38 M483.74%
2003$0.92 M-74.27%
2002$3.58 M-40.97%
2001$6.07 M-40.93%
2000$10.28 M

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of NeoGenomics was reported to be:

$1.67 Billion USD
by Nasdaq info icon info icon
$1.67 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
RadNet
RDNT
$5.72 B 242.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
$15.73 M-99.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
$20.12 B 1,102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$21.10 B 1,161.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
$36.58 M-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA